Treatment · August 8, 2026
Eli Lilly Expands Early Access to Retatrutide for Severely Obese Patients
Eli Lilly provides early access to an innovative weight loss drug for patients, offering hope before formal FDA approval....
Treatment · May 21, 2026
Experimental Triple-Action Drug Retatrutide Matches Bariatric Surgery Weight Loss
Retatrutide clinical trial shows dramatic weight loss results, offering a promising new treatment option....